<h3>Gainers</h3>
<ul>
<li>Quince Therapeutics (NASDAQ:QNCX) stock rose 25.6% to $0.17 during Wednesday's pre-market session. The company's market cap stands at $7.7 million. </li>
<li>LifeStance Health Gr (NASDAQ:LFST) shares moved upwards by 13.86% to $8.13. The market value of their outstanding shares is at $2.7 billion. As per the news, the Q4 earnings report came out today. </li>
<li>Kairos Pharma (AMEX:KAPA) stock rose 11.74% to $0.64. The company's market cap stands at $11.9 million. </li>
<li>Supernus Pharmaceuticals (NASDAQ:SUPN) stock rose 9.94% to $58.6. The company's market cap stands at $2.9 billion. The company's, Q4 earnings came out yesterday. </li>
<li>Akari Therapeutics (NASDAQ:AKTX) stock moved upwards by 9.8% to $0.28. The market value of their outstanding shares is at $9.1 million. </li>
<li>MediciNova (NASDAQ:MNOV) shares rose 9.62% to $1.48. The company's market cap stands at $66.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Edesa Biotech (NASDAQ:EDSA) stock fell 10.6% to $1.35 during Wednesday's pre-market session. The company's market cap stands at $12.6 million. </li>
<li>Fortrea Holdings (NASDAQ:FTRE) stock declined by 9.89% to $9.3. The company's market cap stands at $953.5 million. </li>
<li>Lumexa Imaging Holdings (NASDAQ:LMRI) shares fell 9.66% to $13.0. The market value of their outstanding shares is at $1.3 billion. </li>
<li>BioRestorative Therapies (NASDAQ:BRTX) shares fell 9.39% to $0.24. The company's market cap stands at $6.2 million. </li>
<li>Inogen (NASDAQ:INGN) shares decreased by 9.25% to $5.3. The company's market cap stands at $158.5 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Lunai Bioworks (NASDAQ:LNAI) shares declined by 8.07% to $0.4. The market value of their outstanding shares is at $10.5 million. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SBIO

In Wednesday's pre-market session, Quince Therapeutics (QNCX) saw a significant gain of 25.6%, reaching $0.17, while LifeStance Health (LFST) rose 13.86% to $8.13. Other gainers included Kairos Pharma (KAPA) up 11.74%, Supernus Pharmaceuticals (SUPN) up 9.94%, and Akari Therapeutics (AKTX) up 9.8%. Conversely, Edesa Biotech (EDSA) fell 10.6% to $1.35, Fortrea Holdings (FTRE) declined 9.89%, and Lumexa Imaging Holdings (LMRI) dropped 9.66%. The Q4 earnings reports influenced these movements.

benzinga_article

iShares US Healthcare Providers

Proshares Ultra Nasdaq Biotech

ALPS Medical Breakthrough

LifeStance Health

Ark Genomic Revolution ETF

Kairos Pharma

Fortrea

Lumexa Imaging

iShares Genomics Immunology and Healthcare ETF

VanEck Biotech ETF

SPDR S&P Biotech

First Trust NYSE Arca Biotech Index Fd

iShares US Medical Devices

VG Health

SPDR S&P Health Equip

iShares Biotechnology ETF

Invesco Biotechnology & Genome ETF

Invesco Nasdaq Biotechnology ETF

Supernus Pharma

Quince Therapeutics

Akari Therap

Edesa Biotech

iShares Global Healthcare

Health Care Select Sector SPDR

iShares US Pharma

SPDR S&P Health

12 Health Care Stocks Moving In Wednesday's Pre-Market Session